Abstract

INTRODUCTION: Medulloblastoma (MB), pilocytic astrocytoma (PA), and ependymoma (EP) compose the majority of posterior fossa (PF) pediatric tumors and share similar features on MRI. Pre-operative anticipation of pathology can inform the surgical approach, extent of resection, and potential complications. METHODS: We extracted 1800 Image features from T2- and gadolinium-enhanced T1-weighted images in a multinational cohort of 274 MB, 156 PA, and 97 EP. We designed a two-step classifier—first ruling out PA with a three-way classifier, and next distinguishing MB from EP with a binary classifier. For each step, we selected the best performing classifier model from six candidates following LASSO-feature reduction. Final multi-class classifier performance was measured on a holdout test set with the micro-averaged F1-score. RESULTS: Optimal diagnostic performance was achieved using two decision steps, each with their respective feature set and classifier method. An initial three-way (MB, PA, and EP) logistic regression classifier exhibited a micro-averaged F1-score of 0.739. From a reduced feature set of 61 features, T2-Uniformity and T1-Contrast were the most relevant for distinguishing PA. A subsequent two-way neural net classifier distinguished MB from EP with F1-score 0.9189. In the second reduced feature set of 39 features, T2-Sphericity and T1-Flatness were most relevant. Performing the two classifiers sequentially for MB, PA, and EP classification produced a micro-averaged F1-score of 0.9179. CONCLUSION: A sequential radiomic improved upon a single-step radiographic classifier for pediatric PF tumors. Strong overlap between MB and EP prevented a single-step classifier from distinguishing all three pathologies at once. PA-relevant features aligned with avid gadolinium-enhancement and non-enhancing cystic components. MB and EP-related features correlated to how each conform within and extrude from the fourth ventricle, respectively.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call